Harvard Bioscience (HBIO) Earnings (2010 - 2026)
Harvard Bioscience (HBIO) earnings from Jun 30, 2010 to Mar 31, 2026. The TTM Harvard Bioscience (HBIO) earnings is -$9.78M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
Harvard Bioscience (HBIO) Earnings CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -83.15% |
| 3 Years TTM | +69.45% |
| 5 Years TTM | +19.82% |
| 10 Years TTM | -6.06% |
Annual Earnings change of Harvard Bioscience (HBIO)
| Year | Earnings | Change |
|---|---|---|
| 2026 | -$3.42M | -93.97% |
| 2025 | -$57M | +357.26% |
| 2024 | -$12M | +263.64% |
| 2023 | -$3.41M | -64.18% |
| 2022 | -$9.52M | +3182.76% |
| 2021 | -$290K | -96.29% |
| 2020 | -$7.81M | -1520.00% |
| 2019 | $550K | -118.84% |
| 2018 | -$2.92M | +239.53% |
| 2017 | -$860K | -80.05% |
| 2016 | -$4.31M | -77.36% |
| 2015 | -$19M | -906.78% |
| 2014 | $2.36M | -228.96% |
| 2013 | -$1.83M | -177.22% |
| 2012 | $2.37M | -37.80% |
| 2011 | $3.81M | -79.97% |
| 2010 | $19M | +163.07% |
| 2009 | $7.23M | N/A |
Comparison Harvard Bioscience (HBIO) five years earnings CAGR with competitors
Harvard Bioscience (HBIO) five years earnings CAGR is 19.81%.
| Ticker | Name | five years Earnings CAGR | Upside |
|---|---|---|---|
| MMSI | Merit Medical Systems Inc | 100.79% | +408.76% |
| POCI | Precision Optics Corp Inc | 83.62% | +322.06% |
| OSUR | Orasure Technologies Inc | 81.42% | +310.96% |
| SMTI | Sanara MedTech Inc | 54.72% | +176.19% |
| GCTK | GlucoTrack Inc | 48.38% | +144.18% |
| NYXH | Nyxoah SA | 41.25% | +108.22% |
| STXS | Stereotaxis Inc | 28.42% | +43.46% |
| RMD | Resmed Inc | 27.15% | +37.04% |
| RGNT | Regentis Biomaterials Ltd | 26.99% | +36.25% |
| ZTEK | Zentek Ltd | 21.91% | +10.59% |
| XRAY | DENTSPLY Sirona Inc | 21.23% | +7.18% |
| LMAT | Lemaitre Vascular Inc | 21.08% | +6.42% |
| ISRG | Intuitive Surgical Inc | 20.48% | +3.39% |
| PDEX | Pro-Dex Inc (co) | 14.33% | -27.65% |
| RGEN | Repligen Corp | 10.68% | -46.07% |
| ATR | Aptargroup Inc | 9.76% | -50.74% |
| MBOT | Microbot Medical Inc | 8.73% | -55.93% |
| PLSE | Pulse Biosciences Inc | 5.66% | -71.42% |
| NXGL | Nexgel Inc | 5.49% | -72.29% |
| STVN | Stevanato Group Spa | 5.39% | -72.78% |
| WST | West Pharmaceutical Services Inc | 5.10% | -74.23% |
| UTMD | Utah Medical Products Inc | 0.83% | -95.81% |